-Canada is drawing up plans for extensive tariffs against U.S. products in the event President-elect Donald Trump follows through on his pledge to slap a 25% tariff on all Canadian imports, Bloomberg ...
It was a report as far from Goldilocks as possible -- the unemployment rate lower, and jobs growth much higher, than expected -- and the market responded accordingly: S&P 500 futures slumped by 1% as ...
Friday's surprisingly strong jobs report for December will likely keep the Federal Reserve from significant cuts to interest rates from here, according to Torsten Slok, Apollo Global Management's ...
The parent of the Modelo and Corona beer brands lowered its 2025 outlook, despite third-quarter profit growth.
Treasury yields were climbing Friday as investors weighed a jobs report that was stronger than Wall Street expected. The yield on the 10-year Treasury note was up about 10 basis points at around 4.78% ...
TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) (45%, operator) and its partners Basra Oil Company (30%) and QatarEnergy (25%) launched today the construction works of ArtawiGas25, a first processing ...
Pulse Biosciences has appointed the company's co-chairman, Paul A. LaViolette, as its new chief executive. LaViolette replaces Burke T. Barrett, who was named president and CEO of the ...
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
The U.S. added a bigger-than-expected 256,000 new jobs in December, but most of the increase was concentrated in just a few ...
Royalty Pharma agreed to acquire its external manager, RP Management, in a $1.1 billion deal that it believes will pay for itself in the long-term as it aims to simplify its corporate structure.
Tilray Brands Inc.’s stock fell in premarket trading on Friday after the beer and cannabis company said it expects a $20 ...
Pfizer on Friday said the pivotal Phase 3 study evaluating sasanlimab in combination with standard-of-care Bacillus Calmette-Guerin, or BCG, as induction therapy with or without maintenance in ...